Caitong International Asset Management Co., LTD Collegium Pharmaceutical, Inc Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 20 shares of COLL stock, worth $593. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 20
-0.0%
Holding current value
$593
Previous $573,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding COLL
# of Institutions
245Shares Held
37.2MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$172 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$78.3 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$69.7 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$67.7 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$63.5 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.01B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...